Product Information

GABAPENTIN 400 MG CAPSULE is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.0400 per EA under NDC 31722015005. Its NADAC has been published 146 times since Nov 8, 2023.

FDA first approved this application on May 10, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the gabapentin market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

Price Statistics

The NADAC for GABAPENTIN 400 MG CAPSULE has been published 146 times since Nov 8, 2023, and over the history we have for it it has declined 26.5%. The table below summarizes its recorded NADAC range and movement.

Generic Alternatives

The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.